You are here

Article info

Article menu
Download PDFPDF
Electronic pages
Letter
Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

Authors

  • Baptiste Hervier Internal Medicine department 2, French Reference Centre for Lupus; Hôpital Pitié-Salpêtrière, APHP & University of Paris VI Pierre & Marie Curie, Paris, France PubMed articlesGoogle scholar articles
  • Hervé Devilliers Clinical Investigation Centre, Clinical Epidemiology & Clinical Trials, INSERM CIE1 and Internal Medicine & Systemic Disease Department, University Hospital of Dijon, Dijon, France PubMed articlesGoogle scholar articles
  • Olivier Benveniste Internal Medicine department 1, French Reference Centre for Neuromuscular Disorders; Hôpital Pitié-Salpêtrière, APHP & University of Paris VI Pierre & Marie Curie, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Baptiste Hervier, Service de Médecine Interne 2, Centre National de référence du Lupus, 47-83 boulevard de l'hôpital, Paris, cedex 13 75651, France; bhervier{at}yahoo.fr
View Full Text

Citation

Hervier B, Devilliers H, Benveniste O
Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Annals of the Rheumatic Diseases 2013;72:e18.

Publication history

  • Accepted April 14, 2013
  • First published May 5, 2013.
Online issue publication 
October 31, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions